Jubilant Pharma Limited (“JPL”) a wholly owned subsidiary of Jubilant Life Sciences Ltd. through one of its subsidiaries announced today that it has signed an Agreement to acquire substantially all of the assets which comprise the radiopharmacy business of Triad Isotopes Inc. (“Triad”). See notification below.

Leave a Reply

Share this news!